Waiting for the midterms
But pharmaceutical executives don’t appear comforted by the pushback. “Today it may be childhood vaccines or mRNA, but tomorrow it’s everything,” Noubar Afeyan, co-founder and chairman of…
Continue Reading
News Source: arstechnica.com

Leave a Reply